0907 ET - Investors have been shying away from Jamieson Wellness as they look for the safer haven of larger cap companies, but TD Cowen's Derek Lessard thinks the pullback is unwarranted. So far in the year, the stock has pulled back 15% to C$31.11, nearly wiping out the gains of the past 52 weeks. But there are plenty of positives to drive the stock, including strong contributions from the Chinese market. "With no negative operational news, our positive outlook on 4Q and longer-term is unchanged," he says in a report. The fundamentals are the same, and with the stock down, it "makes the pullback an attractive buying opportunity." (adriano.marchese@wsj.com)
(END) Dow Jones Newswires
February 10, 2025 09:07 ET (14:07 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。